Open Access This article is
- freely available
Metabolites 2019, 9(4), 70; https://doi.org/10.3390/metabo9040070
Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25
Division of Gastroenterology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria and University of Modena and University of Modena and Reggio Emilia, 41124 Modena, Italy
St. Alban-Anlage 66, 4052 Basel, Switzerland
Author to whom correspondence should be addressed.
Received: 9 April 2019 / Accepted: 9 April 2019 / Published: 11 April 2019
As the authors of the title paper , it is with great regret that we inform the readership of Metabolites that we have asked the journal’s publisher, MDPI, to retract the paper from the scientific literature. Due to human error, we included contents similar to article , which has already been published by Pirola et al. We apologize to the readership of Metabolites and to the authors of  for any inconvenience caused.
MDPI is a member of the Committee on Publication Ethics (COPE) and takes the responsibility to enforce strict ethical policies and standards very seriously. To ensure the integrity of the publication record,  is retracted and shall be marked accordingly.
- Carulli, L.; Zanca, G.; Schepis, F.; Villa, E. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9, 25. [Google Scholar] [CrossRef] [PubMed]
- Pirola, C.J.; Sookoian, S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J. Gastroenterol. 2018, 24, 1601–1615. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).